Cargando…
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation
INTRODUCTION: The purpose of this study was to evaluate the effects of risedronate (Ris) in the modulation of bone formation in rats with glucocorticoid (GC)-induced osteoporosis by histomorphometric, immunohistochemical and gene expression analyses. METHODS: We analyzed structure, turnover and micr...
Autores principales: | Valenti, Maria Teresa, Giannini, Sandro, Donatelli, Luca, Zanatta, Mirko, Bertoldo, Francesco, Sella, Stefania, Vilei, Maria Teresa, Ossi, Elena, Realdi, Giuseppe, Lo Cascio, Vincenzo, Dalle Carbonare, Luca |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945066/ https://www.ncbi.nlm.nih.gov/pubmed/20738860 http://dx.doi.org/10.1186/ar3122 |
Ejemplares similares
-
Osteogenic Differentiation in Healthy and Pathological Conditions
por: Valenti, Maria Teresa, et al.
Publicado: (2016) -
The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene?
por: Valenti, Maria Teresa, et al.
Publicado: (2006) -
Ectopic expression of the osteogenic master gene RUNX2 in melanoma
por: Valenti, Maria Teresa, et al.
Publicado: (2018) -
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010) -
Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients
por: Dalle Carbonare, Luca, et al.
Publicado: (2017)